Neptune Technologies & Bioressources Inc. announced that Andre Godin, Neptune’s Chief Financial Officer, will present at the 27th Annual Roth Conference on Tuesday, March 10, 2015 at 4:30 p.m. Pacific Time. The Conference is being held at the Ritz Carlton Hotel in Dana Point, California. A copy of the presentation will be available on the investor section of Neptune’s website at www.neptunebiotech.com/ under the investor events and presentations tab.
Portfolio managers wishing to meet with the Company at the conference should contact a Roth sales representative.
About Neptune Technologies & Bioressources Inc. Neptune is a biotechnology company engaged primarily in the development and commercialization of marine-derived omega-3 polyunsaturated fatty acids (”PUFAs”). Neptune has a patented process of extracting oils from Antarctic krill, and principally sells omega-3 PUFAs as bulk oil to Neptune’s distributors who commercialize them under their private label primarily in the U.S., European and Australian nutraceutical markets.
